Skip to search formSkip to main contentSkip to account menu

CI 941

Known as: CI-941, CI941 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe MCF-7 cell S9 fraction and whole MCF-7 cells can mediate one-electron-redox cycling of doxorubicin, giving rise to… 
2002
2002
The oxidative biotransformation of the anticancer drug 7-hydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-[(2-hydroxyethyl)amino… 
1996
1996
The reversing effect of p-glycoprotein (Pgp) inhibitors on the multidrug resistance (MDR) phenotype is well established in a… 
1993
1993
The anthrapyrazole derivative biantrazole (7-hydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-[(2- hydroxyethyl)amino]ethyl]amino… 
1992
1992
The pharmacokinetics of the anthrapyrazole CI-941 has been investigated in conjunction with the Phase I evaluation of the drug… 
Highly Cited
1991
Highly Cited
1991
Thirty-one patients with advanced breast cancer were treated with CI941, an anthrapyrazole structurally related to mitoxantrone… 
Review
1991
Review
1991
  • I. Judson
  • Anti-cancer drugs
  • 1991
  • Corpus ID: 8473267
The anthrapyrazoles are a new class of intercalating agents which were synthesized in order to reduce the potential for free… 
1986
1986
  • P. Frank, R. Novak
  • Biochemical and biophysical research…
  • 1986
  • Corpus ID: 32460791